Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Filipits

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Anticancer Research|October 23, 2009
CDK10 is not a target for aberrant DNA methylation in breast cancerGerwin Heller, Barbara Ziegler, Anita Brandstetter, et al.
Biomolecules|April 30, 2021
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma PatientsAnna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, et al.
Journal of Medicinal Chemistry|January 4, 2013
X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)Alfred A Hummer, Petra Heffeter, Walter Berger, et al.
Wiener Klinische Wochenschrift|October 9, 2004
Highly refractory acute myeloid leukemiaWolfgang Füreder, Martin Filipits, Wolfgang R Sperr, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 3, 2011
Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinomaChristos Perisanidis, Beata Perisanidis, Fritz Wrba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Cancer Genetics and Cytogenetics|October 14, 2003
Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapyBarbara Fazeny-Dörner, Maria Piribauer, Catharina Wenzel, et al.
Clinical Lung Cancer|September 11, 2018
PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung AdenocarcinomaBojan Zaric, Luka Brcic, Anna Buder, et al.
Neuro-Oncology|February 13, 2010
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsSabine Spiegl-Kreinecker, Christine Pirker, Martin Filipits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence scoreIvana Sestak, Jack Cuzick, Mitch Dowsett, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Anticancer Research|October 23, 2009
CDK10 is not a target for aberrant DNA methylation in breast cancerGerwin Heller, Barbara Ziegler, Anita Brandstetter, et al.
Biomolecules|April 30, 2021
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma PatientsAnna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, et al.
Journal of Medicinal Chemistry|January 4, 2013
X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)Alfred A Hummer, Petra Heffeter, Walter Berger, et al.
Wiener Klinische Wochenschrift|October 9, 2004
Highly refractory acute myeloid leukemiaWolfgang Füreder, Martin Filipits, Wolfgang R Sperr, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 3, 2011
Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinomaChristos Perisanidis, Beata Perisanidis, Fritz Wrba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Cancer Genetics and Cytogenetics|October 14, 2003
Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapyBarbara Fazeny-Dörner, Maria Piribauer, Catharina Wenzel, et al.
Clinical Lung Cancer|September 11, 2018
PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung AdenocarcinomaBojan Zaric, Luka Brcic, Anna Buder, et al.
Neuro-Oncology|February 13, 2010
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsSabine Spiegl-Kreinecker, Christine Pirker, Martin Filipits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence scoreIvana Sestak, Jack Cuzick, Mitch Dowsett, et al.
Pageof 13